Cargando…
P1035: COUNTRY DIFFERENCES IN THE BURDEN OF PATIENTS WITH HYPEREOSINOPHILIC SYNDROME IN EUROPE
Autores principales: | Hwee, J., Kwon, N., Alfonso-Cristancho, R., Baylis, L., Requena, G., Du, S., Khanal, A., Huynh, L., Duh, M. S., Jakes, R. W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430108/ http://dx.doi.org/10.1097/01.HS9.0000847008.81340.c2 |
Ejemplares similares
-
P1034: HEALTHCARE UTILIZATION OF PATIENTS WITH HYPEREOSINOPHILIC SYNDROME IN EUROPE
por: Hwee, J., et al.
Publicado: (2022) -
Response to a case report: Idiopathic hypereosinophilic syndrome in remission with benralizumab treatment after relapse with mepolizumab
por: Requena, Gema, et al.
Publicado: (2021) -
P1035: RING SIDEROBLASTS <15% WAS AN INDEPENDENT RISK FACTOR FOR MYELODYSPLASTIC/MYELOPROLIFERATIVE NEOPLASM WITH SF3B1 MUTATION AND THROMBOCYTOSIS
por: LI, Fuhui, et al.
Publicado: (2023) -
1035. Patient-Reported Outcomes on Long-Acting Cabotegravir + Rilpivirine as Maintenance Therapy: FLAIR 96-Week Results
por: Chounta, Vasiliki, et al.
Publicado: (2020) -
Complications of bronchoscopy for foreign body removal: experience in 1035 cases
por: Hasdiraz, Leyla, et al.
Publicado: (2006)